Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embolization, Therapeutic | 16 | 2024 | 605 | 3.360 |
Why?
|
Hematoma, Subdural, Chronic | 7 | 2024 | 10 | 3.150 |
Why?
|
Thrombectomy | 16 | 2024 | 167 | 2.440 |
Why?
|
Bone Screws | 8 | 2015 | 86 | 2.200 |
Why?
|
Atlanto-Axial Joint | 8 | 2015 | 26 | 1.900 |
Why?
|
Meningeal Arteries | 8 | 2024 | 12 | 1.890 |
Why?
|
Tinnitus | 2 | 2023 | 39 | 1.670 |
Why?
|
Stroke | 16 | 2024 | 1049 | 1.500 |
Why?
|
Intracranial Aneurysm | 8 | 2022 | 130 | 1.480 |
Why?
|
Endovascular Procedures | 9 | 2024 | 471 | 1.310 |
Why?
|
Stents | 11 | 2024 | 999 | 1.070 |
Why?
|
Cranial Sinuses | 2 | 2023 | 24 | 1.060 |
Why?
|
Neurosurgical Procedures | 6 | 2020 | 633 | 1.010 |
Why?
|
Cervical Vertebrae | 2 | 2015 | 219 | 0.890 |
Why?
|
Cerebral Revascularization | 3 | 2023 | 25 | 0.850 |
Why?
|
Constriction, Pathologic | 7 | 2023 | 322 | 0.820 |
Why?
|
Drainage | 2 | 2016 | 462 | 0.800 |
Why?
|
Spinal Fusion | 7 | 2018 | 150 | 0.710 |
Why?
|
Brain Ischemia | 5 | 2023 | 311 | 0.700 |
Why?
|
Treatment Outcome | 43 | 2024 | 33737 | 0.670 |
Why?
|
Cervical Atlas | 2 | 2016 | 21 | 0.650 |
Why?
|
Cerebral Hemorrhage | 4 | 2023 | 190 | 0.620 |
Why?
|
Joint Instability | 3 | 2013 | 78 | 0.620 |
Why?
|
Vertebral Artery | 3 | 2014 | 33 | 0.610 |
Why?
|
Angioplasty | 4 | 2024 | 83 | 0.600 |
Why?
|
Craniotomy | 3 | 2016 | 304 | 0.590 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2022 | 444 | 0.540 |
Why?
|
Arthrodesis | 2 | 2015 | 15 | 0.540 |
Why?
|
Hematoma, Subdural | 1 | 2016 | 30 | 0.530 |
Why?
|
Tranexamic Acid | 1 | 2016 | 23 | 0.530 |
Why?
|
Neurosurgery | 2 | 2014 | 117 | 0.520 |
Why?
|
Antifibrinolytic Agents | 1 | 2016 | 39 | 0.520 |
Why?
|
Orthopedic Procedures | 1 | 2015 | 145 | 0.450 |
Why?
|
Anticoagulants | 3 | 2023 | 775 | 0.450 |
Why?
|
Spinal Injuries | 1 | 2013 | 37 | 0.440 |
Why?
|
Retrospective Studies | 34 | 2024 | 39890 | 0.440 |
Why?
|
Aneurysm, Ruptured | 2 | 2015 | 44 | 0.440 |
Why?
|
Arachnoid | 2 | 2023 | 14 | 0.430 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 176 | 0.420 |
Why?
|
Propensity Score | 3 | 2024 | 772 | 0.410 |
Why?
|
Humans | 75 | 2024 | 270740 | 0.400 |
Why?
|
Prostheses and Implants | 1 | 2014 | 294 | 0.390 |
Why?
|
Heparin | 1 | 2013 | 342 | 0.380 |
Why?
|
Congenital Abnormalities | 1 | 2014 | 280 | 0.370 |
Why?
|
Betacoronavirus | 3 | 2020 | 514 | 0.370 |
Why?
|
Middle Aged | 38 | 2024 | 90352 | 0.370 |
Why?
|
Aneurysm, False | 1 | 2012 | 140 | 0.370 |
Why?
|
Arteries | 1 | 2012 | 291 | 0.370 |
Why?
|
Aged | 33 | 2024 | 73333 | 0.360 |
Why?
|
Spinal Cord | 2 | 2021 | 718 | 0.350 |
Why?
|
Vascular Diseases | 1 | 2012 | 235 | 0.350 |
Why?
|
Middle Cerebral Artery | 3 | 2021 | 113 | 0.340 |
Why?
|
Aged, 80 and over | 19 | 2024 | 30998 | 0.320 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 1034 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 625 | 0.310 |
Why?
|
Surgeons | 1 | 2015 | 491 | 0.310 |
Why?
|
Venous Thromboembolism | 1 | 2013 | 376 | 0.310 |
Why?
|
Male | 41 | 2024 | 128315 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 700 | 0.300 |
Why?
|
Female | 42 | 2024 | 148940 | 0.290 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2022 | 101 | 0.290 |
Why?
|
Registries | 6 | 2024 | 2211 | 0.290 |
Why?
|
Blood Vessel Prosthesis | 3 | 2020 | 368 | 0.290 |
Why?
|
Delivery of Health Care | 1 | 2014 | 855 | 0.280 |
Why?
|
Angiography | 2 | 2020 | 350 | 0.260 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 7783 | 0.240 |
Why?
|
Reperfusion | 2 | 2020 | 25 | 0.230 |
Why?
|
Carotid Artery, Internal | 3 | 2024 | 81 | 0.220 |
Why?
|
Blood Coagulation Disorders | 1 | 2024 | 115 | 0.210 |
Why?
|
Moyamoya Disease | 1 | 2023 | 42 | 0.210 |
Why?
|
Vasospasm, Intracranial | 1 | 2022 | 24 | 0.210 |
Why?
|
Balloon Embolectomy | 2 | 2018 | 2 | 0.210 |
Why?
|
Skull | 3 | 2023 | 251 | 0.200 |
Why?
|
Fetal Stem Cells | 2 | 2012 | 5 | 0.200 |
Why?
|
Drug-Eluting Stents | 1 | 2023 | 77 | 0.200 |
Why?
|
Adult | 18 | 2023 | 82040 | 0.200 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2021 | 14 | 0.200 |
Why?
|
Maternal-Fetal Exchange | 2 | 2012 | 90 | 0.200 |
Why?
|
Urinary Retention | 1 | 2021 | 21 | 0.190 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2021 | 24 | 0.190 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 66 | 0.190 |
Why?
|
Arterial Occlusive Diseases | 1 | 2022 | 149 | 0.190 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2012 | 109 | 0.190 |
Why?
|
Temporal Arteries | 1 | 2021 | 43 | 0.180 |
Why?
|
New York City | 4 | 2021 | 75 | 0.180 |
Why?
|
Brain Infarction | 1 | 2020 | 36 | 0.180 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 23 | 0.180 |
Why?
|
Pons | 1 | 2020 | 54 | 0.180 |
Why?
|
Radiology, Interventional | 1 | 2021 | 142 | 0.180 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2020 | 43 | 0.180 |
Why?
|
Carotid Stenosis | 1 | 2021 | 159 | 0.170 |
Why?
|
Empirical Research | 1 | 2019 | 10 | 0.170 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 59 | 0.170 |
Why?
|
Time-to-Treatment | 4 | 2024 | 307 | 0.170 |
Why?
|
Comprehensive Health Care | 1 | 2020 | 48 | 0.170 |
Why?
|
Arteriovenous Malformations | 1 | 2020 | 65 | 0.170 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 293 | 0.170 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 88 | 0.160 |
Why?
|
Pandemics | 4 | 2021 | 1610 | 0.160 |
Why?
|
Arteriovenous Fistula | 1 | 2020 | 101 | 0.160 |
Why?
|
Skull Base | 2 | 2020 | 225 | 0.160 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 153 | 0.160 |
Why?
|
Catheters | 3 | 2024 | 133 | 0.160 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 165 | 0.150 |
Why?
|
Biomechanical Phenomena | 2 | 2018 | 279 | 0.150 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 250 | 0.150 |
Why?
|
Hyperglycemia | 1 | 2020 | 337 | 0.150 |
Why?
|
Spinal Diseases | 1 | 2018 | 131 | 0.140 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 247 | 0.140 |
Why?
|
Quality Indicators, Health Care | 1 | 2020 | 354 | 0.140 |
Why?
|
Neuroendoscopy | 1 | 2016 | 35 | 0.140 |
Why?
|
Nervous System Neoplasms | 1 | 2016 | 35 | 0.130 |
Why?
|
Epidermal Cyst | 1 | 2016 | 47 | 0.130 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2016 | 42 | 0.130 |
Why?
|
Dermoid Cyst | 1 | 2016 | 39 | 0.130 |
Why?
|
Finite Element Analysis | 1 | 2016 | 54 | 0.130 |
Why?
|
Radiosurgery | 2 | 2016 | 1383 | 0.130 |
Why?
|
Blood Glucose | 1 | 2020 | 1269 | 0.130 |
Why?
|
Confidence Intervals | 2 | 2014 | 749 | 0.130 |
Why?
|
Epilepsy | 2 | 2016 | 931 | 0.130 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2015 | 9 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2016 | 146 | 0.120 |
Why?
|
Vascular Access Devices | 1 | 2015 | 48 | 0.120 |
Why?
|
Health Personnel | 1 | 2020 | 652 | 0.120 |
Why?
|
Tuberous Sclerosis | 1 | 2016 | 145 | 0.120 |
Why?
|
Vascular Patency | 1 | 2015 | 189 | 0.120 |
Why?
|
Printing, Three-Dimensional | 1 | 2016 | 145 | 0.120 |
Why?
|
Hydrocephalus | 1 | 2016 | 259 | 0.110 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 85 | 0.110 |
Why?
|
Cadaver | 1 | 2013 | 202 | 0.110 |
Why?
|
Osteoarthritis, Spine | 1 | 2012 | 1 | 0.110 |
Why?
|
Time Factors | 5 | 2024 | 13006 | 0.110 |
Why?
|
Quality Improvement | 1 | 2020 | 914 | 0.110 |
Why?
|
Physician's Role | 1 | 2015 | 230 | 0.100 |
Why?
|
Patients | 1 | 2015 | 246 | 0.100 |
Why?
|
Thrombosis | 1 | 2018 | 743 | 0.100 |
Why?
|
Alberta | 2 | 2023 | 67 | 0.100 |
Why?
|
Braces | 1 | 2012 | 14 | 0.100 |
Why?
|
Data Collection | 1 | 2015 | 608 | 0.100 |
Why?
|
Arachnoid Cysts | 1 | 2012 | 13 | 0.100 |
Why?
|
Sex Distribution | 1 | 2013 | 497 | 0.100 |
Why?
|
Brain Neoplasms | 2 | 2022 | 4958 | 0.100 |
Why?
|
Case-Control Studies | 1 | 2022 | 6224 | 0.100 |
Why?
|
Glioblastoma | 1 | 2022 | 1776 | 0.100 |
Why?
|
Age Distribution | 1 | 2013 | 727 | 0.100 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 884 | 0.100 |
Why?
|
Hypothalamic Diseases | 1 | 2012 | 42 | 0.100 |
Why?
|
Glioma | 1 | 2022 | 1978 | 0.100 |
Why?
|
Thoracic Vertebrae | 1 | 2012 | 200 | 0.090 |
Why?
|
Hamartoma | 1 | 2012 | 90 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2013 | 418 | 0.090 |
Why?
|
Wounds and Injuries | 1 | 2015 | 437 | 0.090 |
Why?
|
Hospitalization | 2 | 2020 | 2167 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 600 | 0.090 |
Why?
|
Vagus Nerve Stimulation | 1 | 2011 | 63 | 0.090 |
Why?
|
Radiography | 1 | 2014 | 1986 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2024 | 9039 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2016 | 1023 | 0.080 |
Why?
|
Young Adult | 5 | 2016 | 22251 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 909 | 0.080 |
Why?
|
Pilot Projects | 1 | 2016 | 2828 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 3844 | 0.080 |
Why?
|
Risk | 1 | 2013 | 1939 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2012 | 421 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 901 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 705 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2020 | 4372 | 0.070 |
Why?
|
Preoperative Care | 1 | 2014 | 1567 | 0.070 |
Why?
|
Neoplasms | 1 | 2014 | 15927 | 0.070 |
Why?
|
Pain | 1 | 2015 | 1694 | 0.070 |
Why?
|
Cerebral Angiography | 2 | 2018 | 148 | 0.070 |
Why?
|
Myocardium | 1 | 2011 | 1232 | 0.070 |
Why?
|
Adolescent | 4 | 2016 | 32767 | 0.060 |
Why?
|
Prevalence | 1 | 2013 | 3404 | 0.060 |
Why?
|
Infarction, Anterior Cerebral Artery | 1 | 2024 | 3 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1418 | 0.060 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2024 | 7 | 0.060 |
Why?
|
Child | 6 | 2016 | 30559 | 0.060 |
Why?
|
Cell Movement | 1 | 2011 | 2472 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2011 | 1181 | 0.060 |
Why?
|
Polymethyl Methacrylate | 1 | 2023 | 41 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2023 | 72 | 0.050 |
Why?
|
Anterior Cerebral Artery | 1 | 2022 | 8 | 0.050 |
Why?
|
Intention to Treat Analysis | 1 | 2022 | 122 | 0.050 |
Why?
|
Internship and Residency | 1 | 2014 | 1452 | 0.050 |
Why?
|
Dilatation | 1 | 2022 | 87 | 0.050 |
Why?
|
Walruses | 1 | 2021 | 1 | 0.050 |
Why?
|
Paraparesis | 1 | 2021 | 15 | 0.050 |
Why?
|
Intracranial Hemorrhages | 1 | 2022 | 120 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 327 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2021 | 93 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2022 | 222 | 0.050 |
Why?
|
Treatment Failure | 1 | 2024 | 1430 | 0.050 |
Why?
|
Retreatment | 1 | 2022 | 448 | 0.050 |
Why?
|
United States | 2 | 2020 | 15861 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2022 | 230 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2011 | 4116 | 0.050 |
Why?
|
Cranial Fossa, Posterior | 1 | 2020 | 50 | 0.050 |
Why?
|
Cerebral Small Vessel Diseases | 1 | 2020 | 11 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2020 | 38 | 0.040 |
Why?
|
Constipation | 1 | 2021 | 187 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 66 | 0.040 |
Why?
|
Troponin | 1 | 2020 | 87 | 0.040 |
Why?
|
Radial Artery | 1 | 2020 | 35 | 0.040 |
Why?
|
Causality | 1 | 2020 | 176 | 0.040 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 693 | 0.040 |
Why?
|
Thrombophilia | 1 | 2020 | 55 | 0.040 |
Why?
|
Prone Position | 1 | 2020 | 59 | 0.040 |
Why?
|
Personal Protective Equipment | 1 | 2020 | 63 | 0.040 |
Why?
|
Critical Pathways | 1 | 2020 | 160 | 0.040 |
Why?
|
Aphasia | 1 | 2018 | 19 | 0.040 |
Why?
|
Operating Rooms | 1 | 2020 | 128 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2012 | 7381 | 0.040 |
Why?
|
Workflow | 1 | 2020 | 279 | 0.040 |
Why?
|
Biomarkers | 2 | 2020 | 5051 | 0.040 |
Why?
|
Patient Admission | 1 | 2020 | 231 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2014 | 5681 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2020 | 264 | 0.040 |
Why?
|
Cytoreduction Surgical Procedures | 1 | 2022 | 510 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 107 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 196 | 0.040 |
Why?
|
Endoscopy | 1 | 2020 | 496 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 13414 | 0.040 |
Why?
|
Neuroimaging | 1 | 2020 | 401 | 0.030 |
Why?
|
Ultrasonography | 1 | 2023 | 1933 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 2353 | 0.030 |
Why?
|
Brain | 2 | 2022 | 4208 | 0.030 |
Why?
|
Patient Care Team | 1 | 2020 | 823 | 0.030 |
Why?
|
Recovery of Function | 1 | 2018 | 681 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 7895 | 0.030 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 112 | 0.030 |
Why?
|
Cerebral Arteries | 1 | 2015 | 100 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2016 | 303 | 0.030 |
Why?
|
Comorbidity | 1 | 2020 | 2394 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 17888 | 0.030 |
Why?
|
Zygapophyseal Joint | 1 | 2012 | 14 | 0.030 |
Why?
|
Neck Pain | 1 | 2012 | 41 | 0.030 |
Why?
|
Recurrence | 1 | 2020 | 4878 | 0.020 |
Why?
|
CDX2 Transcription Factor | 1 | 2011 | 35 | 0.020 |
Why?
|
Animals | 4 | 2021 | 61956 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 15218 | 0.020 |
Why?
|
Cohort Studies | 1 | 2024 | 9470 | 0.020 |
Why?
|
Headache | 1 | 2012 | 175 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 563 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 6867 | 0.020 |
Why?
|
Infant | 2 | 2016 | 13999 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 483 | 0.020 |
Why?
|
Incidence | 1 | 2020 | 5824 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2011 | 329 | 0.020 |
Why?
|
Vision Disorders | 1 | 2012 | 242 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 1121 | 0.020 |
Why?
|
Child, Preschool | 2 | 2016 | 17061 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 4831 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2011 | 1697 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 657 | 0.020 |
Why?
|
Pregnancy | 2 | 2012 | 8130 | 0.020 |
Why?
|
Calcinosis | 1 | 2012 | 426 | 0.020 |
Why?
|
Reoperation | 1 | 2012 | 1392 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2011 | 430 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 879 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12541 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2011 | 704 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 1125 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2012 | 3045 | 0.020 |
Why?
|
Electroencephalography | 1 | 2011 | 991 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2011 | 2057 | 0.020 |
Why?
|
Biopsy | 1 | 2012 | 3484 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 4223 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 5694 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2016 | 8699 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 7100 | 0.010 |
Why?
|
Mice | 2 | 2012 | 35600 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 5438 | 0.010 |
Why?
|